Pablo Scapellato

974 total citations
29 papers, 162 citations indexed

About

Pablo Scapellato is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Pablo Scapellato has authored 29 papers receiving a total of 162 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 11 papers in Epidemiology and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Pablo Scapellato's work include Streptococcal Infections and Treatments (3 papers), HIV/AIDS drug development and treatment (3 papers) and Trypanosoma species research and implications (3 papers). Pablo Scapellato is often cited by papers focused on Streptococcal Infections and Treatments (3 papers), HIV/AIDS drug development and treatment (3 papers) and Trypanosoma species research and implications (3 papers). Pablo Scapellato collaborates with scholars based in Argentina, Chile and Paraguay. Pablo Scapellato's co-authors include Javier Desse, Gustavo Lopardo, Claudia Pensotti, Analía Mykietiuk, Liliana Clara, Nidia E. Lucero, Isabel Cassetti, Ricardo Negroni, María José López Furst and Sandra M. Ayala and has published in prestigious journals such as SHILAP Revista de lepidopterología, Mayo Clinic Proceedings and Journal of Medical Microbiology.

In The Last Decade

Pablo Scapellato

23 papers receiving 154 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pablo Scapellato Argentina 8 92 56 45 25 15 29 162
Valeria C. Rolla Brazil 8 166 1.8× 107 1.9× 41 0.9× 13 0.5× 18 1.2× 13 230
Matthew Grant United States 9 85 0.9× 88 1.6× 22 0.5× 12 0.5× 17 1.1× 30 172
Simonne A Silva Brazil 10 338 3.7× 46 0.8× 117 2.6× 14 0.6× 26 1.7× 12 386
Roger Hernández Peru 8 71 0.8× 55 1.0× 34 0.8× 13 0.5× 6 0.4× 22 186
Michael Chang United States 8 55 0.6× 59 1.1× 33 0.7× 13 0.5× 32 2.1× 23 223
Jonathan Sellman United States 6 227 2.5× 63 1.1× 22 0.5× 9 0.4× 5 0.3× 9 292
Liliana Clara Argentina 7 94 1.0× 51 0.9× 38 0.8× 13 0.5× 17 1.1× 22 170
Rodolphe Malebranche Haiti 6 89 1.0× 101 1.8× 16 0.4× 28 1.1× 62 4.1× 10 255
Rusmir Baljić Bosnia and Herzegovina 7 88 1.0× 41 0.7× 25 0.6× 14 0.6× 9 0.6× 27 164
Magid Halim Saudi Arabia 9 125 1.4× 90 1.6× 12 0.3× 23 0.9× 4 0.3× 13 206

Countries citing papers authored by Pablo Scapellato

Since Specialization
Citations

This map shows the geographic impact of Pablo Scapellato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Scapellato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Scapellato more than expected).

Fields of papers citing papers by Pablo Scapellato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pablo Scapellato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Scapellato. The network helps show where Pablo Scapellato may publish in the future.

Co-authorship network of co-authors of Pablo Scapellato

This figure shows the co-authorship network connecting the top 25 collaborators of Pablo Scapellato. A scholar is included among the top collaborators of Pablo Scapellato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pablo Scapellato. Pablo Scapellato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nannini, Esteban C., Pablo Scapellato, Andrea Vila, et al.. (2025). Diversity of hypervirulent Klebsiella pneumoniae clones causing cryptogenic liver abscesses and metastatic complications in Argentina. Revista Argentina de Microbiología. 57(4). 356–363. 3 indexed citations
2.
3.
Riera, Fernando, Jorge Alberto Cortés, Pablo Scapellato, et al.. (2023). Antifungal stewardship: the Latin American experience. SHILAP Revista de lepidopterología. 3(1). e217–e217. 8 indexed citations
4.
Scapellato, Pablo & Wanda Cornistein. (2022). La pandemia oculta: resistencia a antimicrobianos. Ley y desafíos. 30.
5.
Hojman, Martín, et al.. (2020). Antibioticoterapia en estadios finales de la vida. 1 indexed citations
6.
Barcán, Laura, María del Carmen Bangher, Laura Barcelona, et al.. (2020). [Intersociety guidelines for diagnosis, treatment and prevention of Clostridioides difficile infections].. PubMed. 80 Suppl 1. 1–32. 2 indexed citations
7.
Furst, María José López, Analía Mykietiuk, Pablo Scapellato, et al.. (2018). Community-acquired uncomplicated urinary tract infections (UTI): current etiology and antimicrobial susceptibility in Argentina. A prospective, observational, multicentre study. International Journal of Infectious Diseases. 73. 7–8.
8.
Scapellato, Pablo, et al.. (2017). [Aerobic etiology of acute appendicitis in adults. Multicenter study of abdominal sepsis in Argentina].. PubMed. 77(2). 121–124. 1 indexed citations
9.
Lopardo, Gustavo, Liliana Clara, Javier Desse, et al.. (2015). [Guidelines for management of community-acquired pneumonia in adults].. PubMed. 75(4). 245–57. 20 indexed citations
10.
Lopardo, Gustavo, Liliana Clara, Gabriel Levy Hara, et al.. (2012). CONSENSO SOBRE DIAGNÓSTICO Y TRATAMIENTO DE INFECCIONES DE VÍAS RESPIRATORIAS ALTAS. 1 indexed citations
11.
Bisio, Margarita, Carolina Cura, Tomás Duffy, et al.. (2009). Linajes de Trypanosoma cruzi en pacientes con enfermedad de Chagas y coinfección por VIH. REVISTA BIOMÉDICA. 20(3). 166–178. 1 indexed citations
12.
Bisio, Margarita, Carolina Cura, Tomás Duffy, et al.. (2009). Trypanosoma cruzi discrete typing units in Chagas disease patients with HIV co-infection. Americanae (AECID Library). 20(3). 166–178. 11 indexed citations
13.
Scapellato, Pablo, et al.. (2008). Rosuvastatina para tratamiento de la dislipidemia en pacientes infectados con VIH en tratamiento antirretroviral de gran actividad. Experiencia preliminar. Enfermedades Infecciosas y Microbiología Clínica. 26(6). 325–329. 10 indexed citations
14.
Hara, Gabriel Levy, Javier Desse, Gustavo Lopardo, et al.. (2008). Consenso SADI-SATI-INE-ADECI: Guía para el manejo racional de la antibioticoterapia en la Unidad de Terapia Intensiva: parte I. 48–64.
15.
Scapellato, Pablo, et al.. (2008). Brucellosis complicating chronic non-infectious disorders: diagnostic and therapeutic dilemmas. Journal of Medical Microbiology. 57(9). 1161–1166. 11 indexed citations
16.
Scapellato, Pablo, et al.. (2006). ¿Es posible la transmision de la enfermedad de Chagas mediante el hábito de compartir jeringas entre pacientes HIV+ adictos a drogas?. Medicina-buenos Aires. 66(6). 595–596. 2 indexed citations
17.
Scapellato, Pablo, et al.. (2004). Osteonecrosis en pacientes infectados por HIV. Medicina-buenos Aires. 64(4). 325–331. 3 indexed citations
18.
Scapellato, Pablo, et al.. (2004). [Clinical, epidemiological and immunological study of patients coinfected with HIV and HTLV-1].. PubMed. 64(5). 413–8. 3 indexed citations
19.
Orduña, Tomás, et al.. (2001). Rickettsioses do grupo das febres maculosas em viajantes argentinos. Revista da Sociedade Brasileira de Medicina Tropical. 34(6). 559–562. 7 indexed citations
20.
Scapellato, Pablo, et al.. (2000). Improvement of Anemia Induced by Parvovirus B19 in a Patient With AIDS After Combined Antiretroviral Therapy. Mayo Clinic Proceedings. 75(2). 215–216. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valeria C. Rolla Breakdown of academic impact, for papers by Matthew Grant Breakdown of academic impact, for papers by Simonne A Silva Breakdown of academic impact, for papers by Roger Hernández Breakdown of academic impact, for papers by Michael Chang Breakdown of academic impact, for papers by Jonathan Sellman Breakdown of academic impact, for papers by Liliana Clara Breakdown of academic impact, for papers by Rodolphe Malebranche Breakdown of academic impact, for papers by Rusmir Baljić Breakdown of academic impact, for papers by Magid Halim
Rankless by CCL
2026